-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EHykxPZCY9HYVCsrbM5I8/D1jyWErSnUVZlHLhTpAiUKntee8RAQSXHFe8enlP6N 6umKnB2h5Bg23E+07jp/rA== 0001179110-06-001801.txt : 20060119 0001179110-06-001801.hdr.sgml : 20060119 20060119184940 ACCESSION NUMBER: 0001179110-06-001801 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060117 FILED AS OF DATE: 20060119 DATE AS OF CHANGE: 20060119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 INDUSTRIAL RD CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6506313100 MAIL ADDRESS: STREET 1: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRAPEAU LOUIS CENTRAL INDEX KEY: 0001248091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 06539194 BUSINESS ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 371 BEL MARIN KEYS BLVD., SUITE 210 CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-506-6700 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 371 BEL MARIN KEYS BLVD., SUITE 210 CITY: NOVATO STATE: CA ZIP: 94949 4 1 edgar.xml FORM 4 - X0202 4 2006-01-17 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001248091 DRAPEAU LOUIS C/O NEKTAR THERAPEUTICS 150 INDUSTRIAL ROAD SAN CARLOS CA 94070 0 1 0 0 Sr. VP Finance, CFO Employee Stock Option (Right to Buy) 20.00 2006-01-17 4 A 0 90000 20.00 A 2016-01-17 Common Stock 90000 0 D The shares being reported were previously disclosed by the Reporting Person in a Form 3 filed on January 19, 2006. The Reporting Person is filing this Form 4 pursuant to Rule 16a 3(g)(1) of the Securities Exchange Act of 1934. 1/5th of the option shares shall vest on January 17, 2007; the remaining shares shall vest monthly thereafter so that all of the shares shall be fully vested on January 17, 2011. /s/ Louis Drapeau 2006-01-19 -----END PRIVACY-ENHANCED MESSAGE-----